Results 201 to 210 of about 103,129 (319)

Exploring the impact of age, sex and life experiences on plasma inflammatory profiles through comparative proteomics. [PDF]

Front Immunol
Bartolucci M, Utyro O, Muraglia A, Repetto A, Agostini V, Pizzonia M, Ottaviani S, Tripodi G, Filaci G, Cancedda R, Petretto A, Mastrogiacomo M.   +11 more
europepmc   +1 more source

Sertraline Treatment Can Mimic Niemann‐Pick Type C Biomarker Profile: A Diagnostic Pitfall

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Oxysterols (cholestane‐3β,5α,6β‐triol and 7‐ketocholesterol) and N‐palmitoyl‐O‐phosphocholineserine (PPCS) are sensitive biomarkers for Niemann‐Pick disease type C (NPC) screening. However, false‐positive results occur, with a biomarker profile suggestive of NPC despite the absence of pathogenic variants in genes involved in NPC or ...
Maria Makrygianni, Cecile Pagan, Antony Citterio‐Quentin, Isabelle Rouvet, Giulia Dingeo, Cyril Hanin, Claudine Laurent‐Levinson, Samia Pichard, Bénédicte Héron, Clément Gourguechon, Daniele Mandia, Jerome Guitton, Carole Lacout, Nicolas Schleinitz, Florient Potier, Olivier Flabeau, Elsa Besse‐Pinot, Foudil Lamari, Magali Pettazzoni, Yann Nadjar   +19 more
wiley   +1 more source

Computation of resistive instabilities in toroidal plasmas

CRPPSPCProc. IAEA Technical Committee Meeting on Advances in Simulation and Modelling of Thermonuclear Plasmas, Montreal, Canada, June 1992 (IAEA, Vienna 1993), p ...
Vlad, G., Lütjens, H., Bondeson, A.
core  

Atmospheric Pressure Plasma for Carbon Material Modification and Synthesis: A Comprehensive Review. [PDF]

Materials (Basel)
Deng S, Takeuchi N, Kaneko T.
europepmc   +1 more source

Comparative Effectiveness and Safety of Inebilizumab Versus Rituximab in AQP4‐IgG‐Positive NMOSD

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Rituximab (anti‐CD20, RTX) and inebilizumab (anti‐CD19, INE) represent B‐cell‐depleting therapies used for aquaporin‐4 antibody‐positive (AQP4‐IgG+) neuromyelitis optica spectrum disorder (NMOSD); however, direct comparative evidence remains limited.
Jie Lin, Binbin Xue, Dewei Xie, Jia Li, Juyuan Pan, Lanbing Zhu, Qiaowen Tong, Jing Lin, Ruofan Zhu, Xu Zhang, Junhui Xia, Xiang Li   +11 more
wiley   +1 more source

MHD Equilibrium and stability of axisymmetric plasmas in the presence of rotation

CRPPSPCProc. of the Workshop on Theory of Fusion Plasmas, Varenna, Italy, August 1987, CEC EUR 112336 EN, 47 - 68 ...
Bhattacharjee, A.
core  

Measurement uncertainty of ISO 17511:2020 compliant and globally standardized PT/INR test results. [PDF]

Res Pract Thromb Haemost
van der Helm MP, van Rijn CJJ, Baktawar SS, Abdoel CF, Kitchen S, Bryant M, Brown P, Tripodi A, Scalambrino E, Clerici M, Herbel P, Jünschke A, Meijer P, Stavelin A, Thelwell C, Cobbaert CM, van den Besselaar AMHP.   +16 more
europepmc   +1 more source

Anti‐CD19 CAR T Cells in Autoimmune Encephalitis: Inflammation Controlled, Neurodegeneration Unchecked?

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Just recently, successful chimeric antigen receptor (CAR) T cell therapy was reported in the first patient with refractory, anti‐diacylglycerol lipase alpha (DAGLA) antibody‐mediated autoimmune encephalitis, achieving partial clinical remission.
Dimitrios Mougiakakos, Marwa Al‐Dubai, Denise Walther, Dominic Borie, Jan D. Lünemann, Marc Pawlitzki, Sven G. Meuth, Solveig Henneicke, Stefan Vielhaber, Stefanie Schreiber   +9 more
wiley   +1 more source

Dehydrogenation vs Apparent Hydrogenation: Unraveling the Mechanisms of He and O₂ Plasma Etching on Colloidal Nanocrystal Films. [PDF]

ACS Appl Mater Interfaces
Shaw S, Silva T, Bobbitt JM, Naab F, Rodrigues CL, Smith EA, Cademartiri L.   +6 more
europepmc   +1 more source

CAR T‐Cell Therapy in Neurology: A Scoping Review of Neuro‐Oncology, Autoimmune Diseases & Neurotoxicity

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Chimeric antigen receptor (CAR) T‐cell therapy has been investigated in neurological diseases, encompassing both central nervous system malignancies and autoimmune disorders, thereby extending its application beyond hematological cancers.
Omar Alqaisi, Mohammed Dibas, Patricia Tai, Ala Dibas, Osama Souied, Suhair Al‐Ghabeesh   +5 more
wiley   +1 more source